Received Mar 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
did not receive the 2nd dose on time; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Patient received first dose in 2019). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: did not receive the 2nd dose on time). The outcome of the incomplete course of vaccination was not applicable. Additional Information: GSK Receipt Date: 11-MAR-2025 Pharmacist called to inform that a patient got a vaccine, Shingrix in 2019 and did not receive the 2nd dose on time, the doctor told she should start the series over. Till the time of reporting, the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination